Ravulizumab-Cwvz
Brand name: Ultomiris
Rank #397 of 500 drugs by total cost
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
$23.1M
Total Cost
428
Total Claims
$23.1M
Total Cost
17
Prescribers
$54K
Cost per Claim
0
Beneficiaries
633
30-Day Fills
$1.4M
Avg Cost/Provider
25
Avg Claims/Provider
Share of Medicare Part D Spending
0.01%
of total Medicare Part D spending
$23.1M of $275.65B
Top Prescribers by Cost
Top 10 prescribers of $23.1M total
🔎 Data Overview
At $53,902 per prescription, this is a high-cost medication. Expensive drugs drive Medicare spending growth and create access challenges for patients with coverage gaps.
Average cost of $1,357,051 per prescriber suggests this drug may be concentrated among specialists. High per-provider spending can sometimes indicate inappropriate prescribing or overly aggressive use.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Top Prescribers of Ravulizumab-Cwvz
| # | Provider | Specialty | Location | Claims | Cost |
|---|---|---|---|---|---|
| 1 | Sami Khella | Neurology | Philadelphia, PA | 93 | $3.7M |
| 2 | Erin Phillips | Neurology | Tyler, TX | 36 | $2.5M |
| 3 | Suraj Muley | Neurology | Phoenix, AZ | 33 | $2.4M |
| 4 | Todd Levine | Neurology | Phoenix, AZ | 32 | $2.3M |
| 5 | Mario Vukic | Neurology | Hackensack, NJ | 29 | $2.1M |
| 6 | Mark Landrio | Neurology | Winchester, VA | 37 | $1.6M |
| 7 | Bonnie Gerecke | Neurology | Baltimore, MD | 23 | $1.1M |
| 8 | Aroucha Vickers | Neurology | Las Vegas, NV | 19 | $1.0M |
| 9 | Amanda Witt | Physical Medicine and Rehabilitation | Jackson, MS | 14 | $1.0M |
| 10 | Mary Sedarous | Neurology | Neptune, NJ | 19 | $863K |
| 11 | Matthew Imperioli | Neurology | Farmington, CT | 12 | $843K |
| 12 | Shaida Khan | Neurology | Dallas, TX | 12 | $756K |
| 13 | Vern Juel | Neurology | Durham, NC | 17 | $680K |
| 14 | Robert Sufit | Neurology | Chicago, IL | 13 | $586K |
| 15 | Jay Johnson | Neurology | Tulsa, OK | 15 | $550K |
Top prescribers ranked by total cost for this drug in 2023.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 394 | Siponimod (Mayzent) | $23.5M | 2,195 |
| 395 | Droxidopa (Droxidopa) | $23.4M | 9,058 |
| 396 | Fenofibrate Nanocrystallized (Fenofibrate) | $23.2M | 602,181 |
| 397 | Ravulizumab-Cwvz (Ultomiris) | $23.1M | 428 |
| 398 | Roflumilast (Roflumilast) | $22.8M | 97,022 |
| 399 | Romosozumab-Aqqg (Evenity (2 Syringes)) | $22.3M | 9,087 |
| 400 | Azithromycin (Azithromycin) | $22.2M | 3,009,458 |
Related Analysis
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology